Search
Filter Results
Displaying 521–530 of 589 results for “retinitis pigmentosa”
-
Share Your Vision: Paula Dubecky
Paula shares her #ShareYourVision story about being diagnosed with retinitis pigmentosa (RP). #blindnessawarenessmonth #blindness #retinitispigmentosa
-
My name is Raquel Alim and I am a legally blind artist from San Diego, California. I was diagnosed with Retinitis Pigmentosa at the young age of 12 and now in my 30’s and not letting blindness stop me from the things I love to do-like creating art.
-
Share Your Vision: Christine Exley
To help spread awareness during October Blindness Awareness Month, we’re inviting you to share your vision-loss journey through written word, audio or video as a part of our October “Share Your Vision” campaign. Visit www.FightingBlindness.org/ShareYourVision to learn more.
-
“My dream career was to be a magazine or newspaper photographer,” recounts Ryck Lent. However, on a day in 1980, just before turning 30, he received a life-altering diagnosis: retinitis pigmentosa (RP). “After that, I knew my life was headed down a different path.”
-
Pat lives in Atlanta and has been working his way up in commercial photography for the last 8 years. He was recently diagnosed with retinitis pigmentosa at age 31.
-
Nicole Rubio was born in New York and graduated from the Museum School of Fine Arts, Boston. She migrated to the West Coast and was diagnosed with retinitis pigmentosa in 1978.
-
Colin was born in the small Western New York Community of Jamestown. His emersion into the arts started naturally, his mother was a designer and his father an art and antiques collector.
-
Jul 21, 2022
RD Fund Announces New Chair, and Expansion of Board of Directors
In the PressRD Fund Board member and seasoned ophthalmology leader Adrienne Graves, PhD, appointed chair. Ophthalmology luminaries Jean Bennett, MD, PhD, Catherine Bowes Rickman, PhD, and José-Alain Sahel, MD, to join the board.
-
Live Stream: XLRP-Patient Focused Drug Development
The live meeting will be to educate FDA staff and other key stakeholders such as biotech and pharmaceutical companies about what it is like to live with XLRP, with perspectives from both affected individuals as well as caregivers and family members of affected individuals.
-
The Karen And Basil Petrou Legacy Education Initiative
The Basil and Karen Petrou Education Initiative is born of the Foundation’s commitment to helping individuals ensure their estates do the best they can for their loved ones and the causes they care about. Debuting this year, the program will offer ongoing resources to help individuals and families explore and learn about end-of-life plans and strategies.